Entheon Biomedical Corp. buy melinda
Start price
22.11.21
/
50%
€0.44
Target price
22.11.22
€0.80
Performance (%)
-95.50%
End price
23.11.22
€0.020
Summary
This prediction ended on 23.11.22 with a price of €0.020. Massive losses of -95.50% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Entheon Biomedical Corp. | - | - | - | - |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% | 59.636% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% | 82.446% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% | 59.334% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% | 55.648% |
According to melinda what are the pros and cons of Entheon Biomedical Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Entheon Biomedical Corp. diskutieren
In the thread Trading Entheon Biomedical Corp.
Die von melinda gewählte maximale Laufzeit wurde überschritten